drugset / Trial / NCT04802408

SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial

NCT04802408

RandomizedFactorialSingle-blindTreatment

Summary

Adults (aged 18-65 years) recently diagnosed with SARS-CoV-2 infection who use a 4-day combined intervention of nasal washes with 1% baby shampoo solution and oral gargles with Listerine Antiseptic® will have a reduced SARS-CoV-2 viral load compared to those using nasal and oral washes with normal saline. This combined intervention should be acceptable, tolerable and safe in this population. To test this, investigators are conducting a trial comparing the efficacy of a number of washes in reducing the oral and nasal SARS-CoV-2 viral load among adults.

Timeline

Start
2021-10-01
Primary completion
2026-05-30
Completion
2026-05-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Baby shampoo Unknown 1 % Intranasal
Subject sodium chloride Unknown

Indications